Loading

Reveal Pharma

June 03, 2024
Company Presentation
Oncology
Company Presentation Theater 1
Reveal is transforming medical insight with the first gadolinium-free general purpose MRI contrast agent RVP-001 (Phase 2 clinical studies) and fibrogenesis-targeted imaging agents (pre-clinical). Our imaging agents are based on technology invented at the Caravan Lab at Harvard Medical School and have broad potential applicability to many disease indications from oncology through CNS to fibrotic diseases for diagnosis, patient management, and study read out.
Reveal Pharma
Company Website: http://www.revealpharma.com
Lead Product in Development: RVP-001 - manganese-based general purpose MRI contrast agent
Number Of Unlicensed Products (For Which You Are Seeking Partners): 2

Company HQ City

Cambridge

Company HQ State

MA

Company HQ Country

United States

CEO/Top Company Official

Vera Hoffman

Development Phase of Primary Product

Phase II
Speakers
Srini Mukundan, PhD
Medical Director
Reveal Pharmaceuticals Inc
Back to Session List

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS